公司资料
Synlogic 股价、新闻与催化剂
- 股票代码:
- SYBX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.16 USD (0.00%)
收盘价
最后更新: 2026年9月17日
—
市值
股价为何变动
截至 2026年9月17日，SYBX 股价变化不大，收于 $1.16。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Synlogic was a synthetic-biology company focused on engineered microbes and metabolic disease before its restructuring and decline. Its platform aimed to use living medicines to address rare disorders.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ before restructuring, Synlogic sat in synthetic biology and biotechnology.
商业模式特征
The company depended on platform validation, clinical proof, and the ability to turn engineered-microbe science into value.
生物医药行业定位
Synlogic belongs to the historical synthetic-biology category rather than the current live public-company set.
未来催化剂
- Synlogic is now mostly a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live pipeline milestone. The market is mainly waiting for clarity on what value, if any, remains.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。